Related Experiment Video
Updated: Jun 5, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
[Basic principles, planning and implementation of non-commercial clinical trials].
1Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127 Bonn. Robert.Finger@ukb.uni-bonn.de
Summary
Investigator-initiated clinical trials (IITs) drive medical progress in areas lacking commercial interest. This review guides inexperienced physicians on conducting IITs according to German regulations, emphasizing quality and participant safety.
Area of Science:
- Clinical pharmacology and therapeutics
- Evidence-based medicine
- Regulatory science
Context:
- Randomized controlled trials (RCTs) are crucial for drug efficacy proof in evidence-based medicine.
- Company-sponsored trials (CSTs) are industry-driven, while investigator-initiated trials (IITs) are typically conducted by universities.
- IITs are vital for medical advancement in areas without commercial interest, leading to treatment optimization.
Purpose:
- To provide guidance for physicians inexperienced in clinical trials.
- To outline the essential elements for conducting IITs under the German Medicinal Products Act.
- To highlight the importance of IITs for scientific progress and improved medical care.
Summary:
- This review details the characterization, responsibilities, and performance of clinical trials, particularly IITs, under German law.
- It addresses the need for profound knowledge, qualified personnel, infrastructure, and financial resources in trial implementation.
- IITs must be managed by universities without pharmaceutical industry support, necessitating comprehensive understanding of regulatory requirements.
Impact:
- Enhances the quality and safety of clinical trials, especially IITs.
- Supports medical professionals in navigating the complexities of clinical trial conduct.
- Contributes to the generation of scientific evidence for treatment optimization and improved patient outcomes.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...